r-1,t-2,3,c-4-Tetrahydroxy-1,2,3,4-tetrahydrophenanthrene (trans, anti-PheT), r-7,t-8,9,c-10-tetrahydroxy-7,8,9,10-tetrahydrobenzo[a]pyrene (trans, anti-BaP-tetraol), and 1-hydroxypyrene in urine
Group . | Mean ± SD (pmol/mg creatinine)a . | . | . | ||
---|---|---|---|---|---|
. | trans, anti-PheT . | trans, anti-BaP-tetraol (×10−3) . | 1-hydroxypyrene . | ||
Psoriasis patients (n = 20) | 791 ± 363 | 41.4 ± 40.9b | 9,390 ± 10,600c | ||
Coke oven workers (n = 32) | 25.7 ± 16.8 | 3.15 ± 3.04b | 100 ± 62.0d | ||
Smokers (n = 31) | 4.58 ± 2.95 | N.A.e | 1.33 ± 1.00 | ||
Nonsmokers (n = 30) | 1.51 ± 1.15 | N.A. | 0.58 ± 0.53 |
Group . | Mean ± SD (pmol/mg creatinine)a . | . | . | ||
---|---|---|---|---|---|
. | trans, anti-PheT . | trans, anti-BaP-tetraol (×10−3) . | 1-hydroxypyrene . | ||
Psoriasis patients (n = 20) | 791 ± 363 | 41.4 ± 40.9b | 9,390 ± 10,600c | ||
Coke oven workers (n = 32) | 25.7 ± 16.8 | 3.15 ± 3.04b | 100 ± 62.0d | ||
Smokers (n = 31) | 4.58 ± 2.95 | N.A.e | 1.33 ± 1.00 | ||
Nonsmokers (n = 30) | 1.51 ± 1.15 | N.A. | 0.58 ± 0.53 |